Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00686634Phase 4Completed
Phase 4, randomised, open-label trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Charles Drew University of Medicine & Science. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00686634.